Brian G. Weinshenker

76.1k total citations · 21 hit papers
293 papers, 47.1k citations indexed

About

Brian G. Weinshenker is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Brian G. Weinshenker has authored 293 papers receiving a total of 47.1k indexed citations (citations by other indexed papers that have themselves been cited), including 237 papers in Pathology and Forensic Medicine, 169 papers in Neurology and 76 papers in Rheumatology. Recurrent topics in Brian G. Weinshenker's work include Multiple Sclerosis Research Studies (226 papers), Peripheral Neuropathies and Disorders (142 papers) and Systemic Lupus Erythematosus Research (54 papers). Brian G. Weinshenker is often cited by papers focused on Multiple Sclerosis Research Studies (226 papers), Peripheral Neuropathies and Disorders (142 papers) and Systemic Lupus Erythematosus Research (54 papers). Brian G. Weinshenker collaborates with scholars based in United States, Canada and Japan. Brian G. Weinshenker's co-authors include Dean M. Wingerchuk, Claudia F. Lucchinetti, Sean J. Pittock, Vanda A. Lennon, John H. Noseworthy, Kazuo Fujihara, Moses Rodriguez, Massimo Filippi, Ludwig Kappos and Chris H. Polman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Genetics.

In The Last Decade

Brian G. Weinshenker

281 papers receiving 45.6k citations

Hit Papers

Diagnostic criteria for multiple s... 1989 2026 2001 2013 2011 2005 2015 2000 2004 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
    2011 7.6k citations Massimo Filippi, Kazuo Fujihara et al. Annals of Neurology profile →
  2. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
    2005 4.0k citations Massimo Filippi, Hans‐Peter Hartung et al. Annals of Neurology profile →
  3. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
    2015 3.0k citations Dean M. Wingerchuk, Brenda Banwell et al. Neurology profile →
  4. Multiple Sclerosis
    2000 2.4k citations Claudia F. Lucchinetti, Brian G. Weinshenker et al. profile →
  5. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
    2004 2.4k citations Vanda A. Lennon, Dean M. Wingerchuk et al. profile →
  6. Revised diagnostic criteria for neuromyelitis optica
    2006 2.0k citations Dean M. Wingerchuk, Vanda A. Lennon et al. Neurology profile →
  7. The spectrum of neuromyelitis optica
    2007 1.6k citations Dean M. Wingerchuk, Vanda A. Lennon et al. profile →
  8. The clinical course of neuromyelitis optica (Devic’s syndrome)
    1999 1.4k citations Dean M. Wingerchuk, Brian G. Weinshenker et al. Neurology profile →
  9. THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY
    1989 1.1k citations Brian G. Weinshenker et al. Brain profile →
  10. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
    2016 700 citations M. Mateo Paz Soldán, Brian G. Weinshenker et al. profile →
  11. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
    1999 601 citations Brian G. Weinshenker, Claudia F. Lucchinetti et al. Annals of Neurology profile →
  12. Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
    2006 552 citations Sean J. Pittock, Brian G. Weinshenker et al. Archives of Neurology profile →
  13. Brain Abnormalities in Neuromyelitis Optica
    2006 523 citations Sean J. Pittock, Vanda A. Lennon et al. Archives of Neurology profile →
  14. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
    2018 502 citations Sven Jarius, Friedemann Paul et al. profile →
  15. THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY
    1989 450 citations Brian G. Weinshenker et al. Brain profile →
  16. Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
    2008 448 citations Sean J. Pittock, Vanda A. Lennon et al. Archives of Neurology profile →
  17. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients
    2017 361 citations Eoin P. Flanagan, Vanda A. Lennon et al. Annals of Neurology profile →
  18. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
    2019 348 citations Massimo Filippi, Paolo Preziosa et al. Brain profile →
  19. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
    2020 317 citations Anthony Traboulsee, Benjamin Greenberg et al. profile →
  20. Neuromyelitis optica
    2020 276 citations Sven Jarius, Friedemann Paul et al. profile →
  21. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders
    2018 256 citations A. Sebastian López‐Chiriboga, Masoud Majed et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian G. Weinshenker United States 84 38.0k 23.8k 12.1k 6.1k 6.0k 293 47.1k
Claudia F. Lucchinetti United States 87 29.0k 0.8× 19.0k 0.8× 8.4k 0.7× 7.3k 1.2× 6.9k 1.2× 231 41.3k
Chris H. Polman Netherlands 98 37.4k 1.0× 13.1k 0.6× 10.3k 0.8× 7.7k 1.3× 7.9k 1.3× 362 48.9k
Xavier Montalbán Spain 89 29.2k 0.8× 11.8k 0.5× 8.4k 0.7× 7.1k 1.2× 6.4k 1.1× 751 39.1k
Fred Lublin United States 52 30.2k 0.8× 10.5k 0.4× 7.7k 0.6× 4.8k 0.8× 5.8k 1.0× 241 37.1k
Ludwig Kappos Switzerland 108 40.8k 1.1× 16.0k 0.7× 10.5k 0.9× 11.2k 1.8× 8.2k 1.4× 818 55.7k
Hans‐Peter Hartung Germany 89 20.7k 0.5× 14.5k 0.6× 5.9k 0.5× 7.9k 1.3× 8.2k 1.4× 730 43.0k
David H. Miller United Kingdom 104 28.5k 0.7× 11.1k 0.5× 8.2k 0.7× 5.7k 0.9× 3.5k 0.6× 389 39.9k
Kazuo Fujihara Japan 59 20.8k 0.5× 13.7k 0.6× 6.3k 0.5× 3.5k 0.6× 3.5k 0.6× 289 25.9k
Vanda A. Lennon United States 97 15.4k 0.4× 26.2k 1.1× 5.9k 0.5× 7.9k 1.3× 5.7k 0.9× 395 41.5k
Jerry S. Wolinsky United States 58 23.4k 0.6× 8.6k 0.4× 6.5k 0.5× 3.3k 0.5× 3.9k 0.6× 243 28.5k

Countries citing papers authored by Brian G. Weinshenker

Since Specialization
Citations

This map shows the geographic impact of Brian G. Weinshenker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian G. Weinshenker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian G. Weinshenker more than expected).

Fields of papers citing papers by Brian G. Weinshenker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian G. Weinshenker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian G. Weinshenker. The network helps show where Brian G. Weinshenker may publish in the future.

Co-authorship network of co-authors of Brian G. Weinshenker

This figure shows the co-authorship network connecting the top 25 collaborators of Brian G. Weinshenker. A scholar is included among the top collaborators of Brian G. Weinshenker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian G. Weinshenker. Brian G. Weinshenker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, Jeffrey L., Kazuo Fujihara, Albert Saiz, et al.. (2025). Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study. Neurology Neuroimmunology & Neuroinflammation. 12(6). e200494–e200494. 1 indexed citations
2.
Bennett, Jeffrey L., Kazuo Fujihara, Albert Saiz, et al.. (2025). Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study. Neurology Neuroimmunology & Neuroinflammation. 12(5). e200450–e200450. 1 indexed citations
3.
Keegan, B. Mark, Steven A. Messina, Dennis P. Hanson, et al.. (2024). MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment. American Journal of Neuroradiology. 45(7). 943–950. 4 indexed citations
4.
Hoffman, E. Matthew, et al.. (2024). McArdle sign and neck flexion-induced change in central motor conduction in multiple sclerosis. Multiple Sclerosis Journal. 30(14). 1830–1834.
5.
Weinshenker, Brian G., Dean M. Wingerchuk, Ari Green, et al.. (2023). Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum. Multiple Sclerosis Journal. 29(8). 945–955. 5 indexed citations
6.
Flanagan, Eoin P., et al.. (2023). Laboratory evaluation for the differential diagnosis of possible multiple sclerosis in the United States: A physician survey. Journal of the Neurological Sciences. 453. 120781–120781. 1 indexed citations
7.
Majed, Masoud, Cristina Valencia-Sánchez, Jeffrey L. Bennett, et al.. (2023). Alterations in Aquaporin‐4‐IgG Serostatus in 986 Patients: A Laboratory‐Based Longitudinal Analysis. Annals of Neurology. 94(4). 727–735. 15 indexed citations
8.
Flanagan, Eoin P., et al.. (2022). Progressive motor impairment from “critical” demyelinating lesions of the cervicomedullary junction. Multiple Sclerosis Journal. 29(1). 74–80. 7 indexed citations
9.
Contentti, Edgar Carnero, Pablo A. López, Juan Criniti, et al.. (2022). Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors. Multiple Sclerosis Journal. 29(2). 277–286. 14 indexed citations
10.
11.
Bryant, Sandra C., Andrew McKeon, Brian G. Weinshenker, et al.. (2021). CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis. Mayo Clinic Proceedings. 97(4). 738–751. 28 indexed citations
12.
Hašková, Zdenka, Benjamin Greenberg, Jeffrey L. Bennett, et al.. (2021). Efficacy and safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD): Results from open-label extension periods of SAkuraSky and SAkuraStar. Investigative Ophthalmology & Visual Science. 62(8). 3475–3475. 1 indexed citations
13.
Sechi, Elia, Eelco F. M. Wijdicks, Sean J. Pittock, et al.. (2021). CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. 97(13). e1351–e1358. 32 indexed citations
14.
Redenbaugh, Vyanka, Mayra Montalvo, Elia Sechi, et al.. (2021). Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080415856–3080415856. 31 indexed citations
15.
Floris, Valentina, Eoin P. Flanagan, A. Sebastian López‐Chiriboga, et al.. (2021). Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080411961–3080411961. 8 indexed citations
16.
Banks, Samantha A., Padraig P. Morris, John J. Chen, et al.. (2020). Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. Journal of Neurology Neurosurgery & Psychiatry. 92(4). 384–390. 76 indexed citations
17.
Filippi, Massimo, Paolo Preziosa, Brenda Banwell, et al.. (2019). Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 142(7). 1858–1875. 348 indexed citations breakdown →
18.
Wingerchuk, Dean M., Brenda Banwell, Jeffrey L. Bennett, et al.. (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85(2). 177–189. 2985 indexed citations breakdown →
19.
Pirko, Istvan, et al.. (2004). The Natural History of Recurrent Optic Neuritis. Archives of Neurology. 61(9). 1401–1401. 87 indexed citations
20.
Weinshenker, Brian G.. (1996). Long-term and Short-term Outcome of Multiple Sclerosis. Archives of Neurology. 53(4). 353–353. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia F. Lucchinetti Breakdown of academic impact, for papers by Chris H. Polman Breakdown of academic impact, for papers by Xavier Montalbán Breakdown of academic impact, for papers by Fred Lublin Breakdown of academic impact, for papers by Ludwig Kappos Breakdown of academic impact, for papers by Hans‐Peter Hartung Breakdown of academic impact, for papers by David H. Miller Breakdown of academic impact, for papers by Kazuo Fujihara Breakdown of academic impact, for papers by Vanda A. Lennon Breakdown of academic impact, for papers by Jerry S. Wolinsky
Rankless by CCL
2026